Effects and action mechanisms of berberine and Rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL/6J mice
about
Effect of Rhizoma coptidis (Huang Lian) on Treating Diabetes MellitusEfficacy of Berberine in Patients with Non-Alcoholic Fatty Liver DiseaseRhizoma Coptidis: A Potential Cardiovascular Protective AgentNatural Dietary and Herbal Products in Anti-Obesity TreatmentDose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer CellsBerberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels.Ephedra-Treated Donor-Derived Gut Microbiota Transplantation Ameliorates High Fat Diet-Induced Obesity in Rats.Uncoupling protein-2 mediates the protective action of berberine against oxidative stress in rat insulinoma INS-1E cells and in diabetic mouse islets.A review on the traditional Chinese medicinal herbs and formulae with hypolipidemic effect.Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trialWeight loss herbal intervention therapy (W-LHIT) a non-appetite suppressing natural product controls weight and lowers cholesterol and glucose levels in a murine modelAnanas comosus L. Leaf Phenols and p-Coumaric Acid Regulate Liver Fat Metabolism by Upregulating CPT-1 Expression.Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed ratsAnti-hyperlipidemic effects and potential mechanisms of action of the caffeoylquinic acid-rich Pandanus tectorius fruit extract in hamsters fed a high fat-diet.Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus.Application of berberine on treating type 2 diabetes mellitus.Oral Exposure of Mice to Carbendazim Induces Hepatic Lipid Metabolism Disorder and Gut Microbiota Dysbiosis.Transforming berberine into its intestine-absorbable form by the gut microbiotaModulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats.Calcium supplementation modulates gut microbiota in a prebiotic manner in dietary obese mice.Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.Gut Microbiota and ObesityBerberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironmentHataedock Treatment Has Preventive Therapeutic Effects in Atopic Dermatitis-Induced NC/Nga Mice under High-Fat Diet Conditions.Update on berberine in nonalcoholic Fatty liver disease.Oral administration of alkylglycerols differentially modulates high-fat diet-induced obesity and insulin resistance in mice.Renal Protective Role of Xiexin Decoction with Multiple Active Ingredients Involves Inhibition of Inflammation through Downregulation of the Nuclear Factor-κB Pathway in Diabetic Rats.Hypolipidemic effects of HVC1 in a high cholesterol diet‑induced rat model of hyperlipidemia.Jiao tai wan attenuates hepatic lipid accumulation in type 2 diabetes mellitusAntidiabetic properties of berberine: from cellular pharmacology to clinical effects.Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials.Gastrointestinal hormones and polycystic ovary syndrome.Probiotics as beneficial agents in the management of diabetes mellitus: a systematic review.Berberis Vulgaris and Berberine: An Update Review.The metabolism of berberine and its contribution to the pharmacological effects.In Vitro Screening for Antihepatic Steatosis Active Components within Coptidis Rhizoma Alkaloids Extract Using Liver Cell Extraction with HPLC Analysis and a Free Fatty Acid-Induced Hepatic Steatosis HepG2 Cell AssayModulation of Microbiota-Gut-Brain Axis by Berberine Resulting in Improved Metabolic Status in High-Fat Diet-Fed Rats.Uncoupling Protein 2: A Key Player and a Potential Therapeutic Target in Vascular Diseases.Balancing Herbal Medicine and Functional Food for Prevention and Treatment of Cardiometabolic Diseases through Modulating Gut Microbiota.
P2860
Q26778280-E9EC00E8-471E-4165-A4E5-0AD92D8D917EQ27301440-E4731201-8A57-4DB0-9150-4D3F79A86743Q28067054-C3B34E4F-DF68-4909-8665-398DA4BA40EFQ28072291-06DE3344-076C-4755-B0F9-8EAC60BCCA0BQ28542653-FD2DC862-017F-4B46-B269-C5F39992D3E8Q33671672-248ED81E-A0C0-4F31-97B4-CBCE0D78598EQ33839421-E7D42727-1C2B-4712-AA78-7DA96CA9244AQ33842742-D4E8FF5F-4DC8-435E-ACE7-0CC1E6881510Q33942724-614AA936-1EA0-45D2-B685-2F41BA78A889Q33988933-829BF167-0977-416C-8673-06E7034475F4Q34017884-6D6D2B85-DC14-4CFA-9012-3FE5B94C906AQ34093727-090799C1-01AB-4EE7-831A-3A6097AACB4DQ34374252-E846751C-4213-4ECD-A60D-16FB4D2D1F93Q34685423-6972A117-CD7B-4820-8694-0A239618E201Q35145862-2805E753-C8C2-4012-813A-5AF555F28D44Q35226998-30BC62E4-EB8E-4EC8-8858-7B1E42C61464Q35662801-A4B73DFA-DDA2-47CB-AEE6-758CDAD96097Q35691271-07138588-0722-4D63-BB37-23C883DDF211Q35784335-9FA553C1-BFB3-43B0-98C3-02534065372EQ35845777-A3AFAE49-7B00-4AE5-BBB5-25A7DA83B5F2Q36216779-DA17E7AC-4F94-4D8A-956E-84730F8E7A3FQ36292252-0E8E6571-9FBC-4CC0-8DEF-9E3BDD378B61Q36340772-C12B9141-2E2B-4A07-96D6-F28B141B96F3Q36544753-E9BEE8D1-F7BA-43DA-A591-72AF9EEA5023Q36973928-3212DE3C-4227-4DF4-9B10-57CDDC3D1C24Q36988577-7B365B60-1CBC-4E00-82CF-7A00537B387BQ36995258-A7AE8310-F805-40EA-834B-F12C66B05A64Q37019804-8FC4728C-D86E-4895-BF34-7F1C71830257Q37297532-BFD541A6-CA61-4D67-BEF9-8421338472D7Q37351506-F0D5CFB3-42F1-4B17-BF63-ABCB9E901B06Q38012073-184D34F4-886A-4B67-B00D-AF76574DAFCFQ38025153-544FA3A5-8372-4C4B-9695-FB9D8C85B191Q38208929-C4E2096C-A248-489A-AF9E-6DC688CFC104Q38473701-CB8D5CD7-9B02-47A1-940C-F74407DC86E0Q38928488-3EFF556D-EA3A-41E1-9727-C37658155C3EQ39177350-85944CB4-E694-4916-879D-FA124B4FF9B4Q41846030-47DD4CAA-9FD2-410E-A117-18BFED680C5FQ45159552-3A79A3C4-FA73-40A2-A757-CE86F75320CFQ45414884-AD6B8833-5249-4D87-850B-E1229848B32BQ45849451-61AF23F1-2020-4DB2-9A6C-B345F555015B
P2860
Effects and action mechanisms of berberine and Rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL/6J mice
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Effects and action mechanisms ...... igh-fat diet-fed C57BL/6J mice
@ast
Effects and action mechanisms ...... igh-fat diet-fed C57BL/6J mice
@en
Effects and action mechanisms ...... igh-fat diet-fed C57BL/6J mice
@nl
type
label
Effects and action mechanisms ...... igh-fat diet-fed C57BL/6J mice
@ast
Effects and action mechanisms ...... igh-fat diet-fed C57BL/6J mice
@en
Effects and action mechanisms ...... igh-fat diet-fed C57BL/6J mice
@nl
prefLabel
Effects and action mechanisms ...... igh-fat diet-fed C57BL/6J mice
@ast
Effects and action mechanisms ...... igh-fat diet-fed C57BL/6J mice
@en
Effects and action mechanisms ...... igh-fat diet-fed C57BL/6J mice
@nl
P2093
P2860
P3181
P1433
P1476
Effects and action mechanisms ...... igh-fat diet-fed C57BL/6J mice
@en
P2093
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0024520
P407
P577
2011-01-01T00:00:00Z